Sign in Subscribe

Twist Bioscience Shares Jump on Record Revenue, Raised Guidance and Path to Profitability

Twist Bioscience shares rose after record $118.4M Q3 revenue (+23% YoY), 14th sequential growth quarter, raised FY26 outlook, and path to EBITDA breakeven.

Twist Bioscience Shares Jump on Record Revenue, Raised Guidance and Path to Profitability
Credit: Twist Bioscience
Already have an account? Sign in.